Soquinolol

Chemical structure of Soquinolol

Soquinolol is a beta-adrenergic antagonist (beta-blocker) that is primarily used in the management of cardiovascular diseases. It is a non-selective beta-blocker, meaning it inhibits both beta-1 and beta-2 adrenergic receptors. This class of drugs is commonly used to treat conditions such as hypertension, angina pectoris, and certain types of arrhythmias.

Mechanism of Action

Soquinolol works by blocking the effects of epinephrine (adrenaline) and norepinephrine on beta-adrenergic receptors. By inhibiting these receptors, soquinolol reduces the heart rate, decreases cardiac output, and lowers blood pressure. This action helps to reduce the workload on the heart and is beneficial in treating hypertension and angina.

Pharmacokinetics

Soquinolol is administered orally and is well absorbed from the gastrointestinal tract. It undergoes hepatic metabolism and is excreted primarily in the urine. The half-life of soquinolol allows for once or twice daily dosing, depending on the clinical scenario and patient needs.

Clinical Uses

Soquinolol is indicated for the treatment of:

• Hypertension
• Angina pectoris
• Arrhythmias, particularly supraventricular arrhythmias
• Heart failure (in certain cases, as part of a comprehensive treatment plan)

Side Effects

Common side effects of soquinolol include:

• Bradycardia (slow heart rate)
• Hypotension (low blood pressure)
• Fatigue
• Dizziness
• Cold extremities

Less common but serious side effects can include:

• Bronchospasm, particularly in patients with asthma or COPD
• Heart block
• Depression

Contraindications

Soquinolol should not be used in patients with:

• Asthma or severe chronic obstructive pulmonary disease (COPD)
• Bradycardia
• Heart block greater than first degree
• Cardiogenic shock

Related Pages

• Beta blocker
• Hypertension
• Angina pectoris
• Arrhythmia